Literature DB >> 15379277

[Value of measurements of blood flow velocity in central retinal artery in thyroid-associated ophthalmopathy].

Hui Li1, Yu-hua Liu, Dong-hui Li, Yue Zhang.   

Abstract

OBJECTIVE: To study the clinical values of measurement of blood flow velocity in central retinal artery in thyroid-associated ophthalmopathy (TAO).
METHODS: Thirty normal subjects without any thyroid disorders or any eye abnormalities were assigned into the control group, and 30 TAO patients were assigned into the TAO group. Color Doppler ultrasonography was done to measure the blood flow velocity in central retinal artery. Measurement results were compared between these two groups.
RESULTS: The peak systolic velocity and end diastolic velocity of blood flow were significantly lower in TAO group (P < 0.001), while the resistance index significantly increased (P < 0.001).
CONCLUSION: Measurement of blood flow velocity in central retinal artery with Color Doppler ultrasonography is an easy and useful way to appraise the hemodynamics of the central retinal artery in TAO patients.

Entities:  

Mesh:

Year:  2004        PMID: 15379277

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  3 in total

1.  Effect of smoking on retrobulbar blood flow in thyroid eye disease.

Authors:  A Sadeghi-Tari; M Jamshidian-Tehrani; A Nabavi; S Sharif-Kashani; E Elhami; N Hassanpour; K Ameli Zamani
Journal:  Eye (Lond)       Date:  2016-08-19       Impact factor: 3.775

2.  Analysis in Choroidal Thickness in Patients with Graves' Ophthalmopathy Using Spectral-Domain Optical Coherence Tomography.

Authors:  Nan Yu; Yadi Zhang; Lei Kang; Ying Gao; Junqing Zhang; Yuan Wu
Journal:  J Ophthalmol       Date:  2018-12-23       Impact factor: 1.909

3.  Analysis of Foveal and Parafoveal Microvascular Density and Retinal Vessel Caliber Alteration in Inactive Graves' Ophthalmopathy.

Authors:  Cetin Akpolat; Muhammed M Kurt; Merve Yılmaz; Fikriye Ordulu; Ferhat Evliyaoglu
Journal:  J Ophthalmol       Date:  2020-03-19       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.